Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser
To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2...
Gespeichert in:
| Veröffentlicht in: | Lasers in medical science 2021-03, Vol.36 (2), p.317-323 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 323 |
|---|---|
| container_issue | 2 |
| container_start_page | 317 |
| container_title | Lasers in medical science |
| container_volume | 36 |
| creator | Arslan, Umut |
| description | To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2019, included 32 eyes of 29 patients who had cystoid macular edema secondary to retinitis pigmentosa. Patients were treated by subliminal micropulse yellow laser for one session. Central macular thickness and best-corrected visual acuity changes were investigated just before the treatment and 1 year later after the one session of the treatment. The mean central macular thickness was 651.3 μm before the treatment and 247.7 μm at 12 months after the treatment. The decrease in mean central macular thickness was statistically significant (
p
= 0.01). Median best-corrected visual acuity was 66.8 ETDRS letters before the treatment and 70.0 letters at 12 months after the treatment. The increase in best-corrected visual acuity was not statistically significant (
p
= 0.18). Eighty-six percent of the patients stated that the quality of central vision increased and that color vision, contrast sensitivity, and distortion improved. We did not encounter any serious adverse events related to the application of subliminal micropulse yellow laser. The subliminal micropulse yellow laser seems to be a therapeutic, effective, and safe option for the treatment of non-inflammatory and resistant cystoid macular edema secondary to retinitis pigmentosa patients.
ClinicalTrials.gov
ID: NCT04234438, January 17, 2020. |
| doi_str_mv | 10.1007/s10103-020-03031-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2398162636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489035728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-406f6951b996dbe9bf9f135f5691a9416c2eb32a848716105bbcaab685281203</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVpaDbbfoEegqCXXJzOSLYsHUvIP0joZQ-5CcmWFwXb2kh2y377aOtNCz3kJBj95s3Me4R8RbhEgPp7QkDgBTAogAPHAj6QFZa8KgSUTx_JCpiQhVQMT8lZSs8AWAvkn8gpZ1zwktcr0j-a0Wzd4MaJho42-zQF39LBNHNvInWtGwxNrglja-KeToFGN_nRTz7Rnd8e-kIy9JfP1Gx7P_jR9HTwTQy7uU-O7l3fh9-0N8nFz-SkM7n45fiuyebmenN1Vzz8vL2_-vFQNLyupqIE0QlVoVVKtNYp26kOedVVQqFRJYqGOcuZkaWsUSBU1jbGWCErJpEBX5OLRXYXw8vs0qQHn5q8hxldmJNmXEkUTGQP1uTbf-hzmGM-IVOlVMCrmslMsYXKV6UUXad30Q_ZD42gD1HoJQqdo9B_otCHLc6P0rMdXPu35c37DPAFSPlr3Lr4b_Y7sq8UwJSf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489035728</pqid></control><display><type>article</type><title>Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Arslan, Umut</creator><creatorcontrib>Arslan, Umut</creatorcontrib><description>To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2019, included 32 eyes of 29 patients who had cystoid macular edema secondary to retinitis pigmentosa. Patients were treated by subliminal micropulse yellow laser for one session. Central macular thickness and best-corrected visual acuity changes were investigated just before the treatment and 1 year later after the one session of the treatment. The mean central macular thickness was 651.3 μm before the treatment and 247.7 μm at 12 months after the treatment. The decrease in mean central macular thickness was statistically significant (
p
= 0.01). Median best-corrected visual acuity was 66.8 ETDRS letters before the treatment and 70.0 letters at 12 months after the treatment. The increase in best-corrected visual acuity was not statistically significant (
p
= 0.18). Eighty-six percent of the patients stated that the quality of central vision increased and that color vision, contrast sensitivity, and distortion improved. We did not encounter any serious adverse events related to the application of subliminal micropulse yellow laser. The subliminal micropulse yellow laser seems to be a therapeutic, effective, and safe option for the treatment of non-inflammatory and resistant cystoid macular edema secondary to retinitis pigmentosa patients.
ClinicalTrials.gov
ID: NCT04234438, January 17, 2020.</description><identifier>ISSN: 0268-8921</identifier><identifier>EISSN: 1435-604X</identifier><identifier>DOI: 10.1007/s10103-020-03031-0</identifier><identifier>PMID: 32363437</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Acuity ; Adolescent ; Adult ; Adverse events ; Aged ; Color sensitivity ; Color vision ; Dentistry ; Edema ; Eye (anatomy) ; Female ; Humans ; Inflammation ; Laser applications ; Laser Therapy ; Lasers ; Macular Edema - etiology ; Macular Edema - physiopathology ; Macular Edema - surgery ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Optical Devices ; Optics ; Original Article ; Patients ; Photonics ; Prospective Studies ; Quantum Optics ; Retinitis ; Retinitis pigmentosa ; Retinitis Pigmentosa - complications ; Statistical analysis ; Thickness ; Visual Acuity ; Young Adult</subject><ispartof>Lasers in medical science, 2021-03, Vol.36 (2), p.317-323</ispartof><rights>Springer-Verlag London Ltd., part of Springer Nature 2020</rights><rights>Springer-Verlag London Ltd., part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-406f6951b996dbe9bf9f135f5691a9416c2eb32a848716105bbcaab685281203</citedby><cites>FETCH-LOGICAL-c375t-406f6951b996dbe9bf9f135f5691a9416c2eb32a848716105bbcaab685281203</cites><orcidid>0000-0003-4146-8083</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10103-020-03031-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10103-020-03031-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32363437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arslan, Umut</creatorcontrib><title>Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser</title><title>Lasers in medical science</title><addtitle>Lasers Med Sci</addtitle><addtitle>Lasers Med Sci</addtitle><description>To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2019, included 32 eyes of 29 patients who had cystoid macular edema secondary to retinitis pigmentosa. Patients were treated by subliminal micropulse yellow laser for one session. Central macular thickness and best-corrected visual acuity changes were investigated just before the treatment and 1 year later after the one session of the treatment. The mean central macular thickness was 651.3 μm before the treatment and 247.7 μm at 12 months after the treatment. The decrease in mean central macular thickness was statistically significant (
p
= 0.01). Median best-corrected visual acuity was 66.8 ETDRS letters before the treatment and 70.0 letters at 12 months after the treatment. The increase in best-corrected visual acuity was not statistically significant (
p
= 0.18). Eighty-six percent of the patients stated that the quality of central vision increased and that color vision, contrast sensitivity, and distortion improved. We did not encounter any serious adverse events related to the application of subliminal micropulse yellow laser. The subliminal micropulse yellow laser seems to be a therapeutic, effective, and safe option for the treatment of non-inflammatory and resistant cystoid macular edema secondary to retinitis pigmentosa patients.
ClinicalTrials.gov
ID: NCT04234438, January 17, 2020.</description><subject>Acuity</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Aged</subject><subject>Color sensitivity</subject><subject>Color vision</subject><subject>Dentistry</subject><subject>Edema</subject><subject>Eye (anatomy)</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Laser applications</subject><subject>Laser Therapy</subject><subject>Lasers</subject><subject>Macular Edema - etiology</subject><subject>Macular Edema - physiopathology</subject><subject>Macular Edema - surgery</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Optical Devices</subject><subject>Optics</subject><subject>Original Article</subject><subject>Patients</subject><subject>Photonics</subject><subject>Prospective Studies</subject><subject>Quantum Optics</subject><subject>Retinitis</subject><subject>Retinitis pigmentosa</subject><subject>Retinitis Pigmentosa - complications</subject><subject>Statistical analysis</subject><subject>Thickness</subject><subject>Visual Acuity</subject><subject>Young Adult</subject><issn>0268-8921</issn><issn>1435-604X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU9r3DAQxUVpaDbbfoEegqCXXJzOSLYsHUvIP0joZQ-5CcmWFwXb2kh2y377aOtNCz3kJBj95s3Me4R8RbhEgPp7QkDgBTAogAPHAj6QFZa8KgSUTx_JCpiQhVQMT8lZSs8AWAvkn8gpZ1zwktcr0j-a0Wzd4MaJho42-zQF39LBNHNvInWtGwxNrglja-KeToFGN_nRTz7Rnd8e-kIy9JfP1Gx7P_jR9HTwTQy7uU-O7l3fh9-0N8nFz-SkM7n45fiuyebmenN1Vzz8vL2_-vFQNLyupqIE0QlVoVVKtNYp26kOedVVQqFRJYqGOcuZkaWsUSBU1jbGWCErJpEBX5OLRXYXw8vs0qQHn5q8hxldmJNmXEkUTGQP1uTbf-hzmGM-IVOlVMCrmslMsYXKV6UUXad30Q_ZD42gD1HoJQqdo9B_otCHLc6P0rMdXPu35c37DPAFSPlr3Lr4b_Y7sq8UwJSf</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Arslan, Umut</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7SP</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H8D</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>L7M</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4146-8083</orcidid></search><sort><creationdate>20210301</creationdate><title>Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser</title><author>Arslan, Umut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-406f6951b996dbe9bf9f135f5691a9416c2eb32a848716105bbcaab685281203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acuity</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Aged</topic><topic>Color sensitivity</topic><topic>Color vision</topic><topic>Dentistry</topic><topic>Edema</topic><topic>Eye (anatomy)</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Laser applications</topic><topic>Laser Therapy</topic><topic>Lasers</topic><topic>Macular Edema - etiology</topic><topic>Macular Edema - physiopathology</topic><topic>Macular Edema - surgery</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Optical Devices</topic><topic>Optics</topic><topic>Original Article</topic><topic>Patients</topic><topic>Photonics</topic><topic>Prospective Studies</topic><topic>Quantum Optics</topic><topic>Retinitis</topic><topic>Retinitis pigmentosa</topic><topic>Retinitis Pigmentosa - complications</topic><topic>Statistical analysis</topic><topic>Thickness</topic><topic>Visual Acuity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arslan, Umut</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Electronics & Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Aerospace Database</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lasers in medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arslan, Umut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser</atitle><jtitle>Lasers in medical science</jtitle><stitle>Lasers Med Sci</stitle><addtitle>Lasers Med Sci</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>36</volume><issue>2</issue><spage>317</spage><epage>323</epage><pages>317-323</pages><issn>0268-8921</issn><eissn>1435-604X</eissn><abstract>To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2019, included 32 eyes of 29 patients who had cystoid macular edema secondary to retinitis pigmentosa. Patients were treated by subliminal micropulse yellow laser for one session. Central macular thickness and best-corrected visual acuity changes were investigated just before the treatment and 1 year later after the one session of the treatment. The mean central macular thickness was 651.3 μm before the treatment and 247.7 μm at 12 months after the treatment. The decrease in mean central macular thickness was statistically significant (
p
= 0.01). Median best-corrected visual acuity was 66.8 ETDRS letters before the treatment and 70.0 letters at 12 months after the treatment. The increase in best-corrected visual acuity was not statistically significant (
p
= 0.18). Eighty-six percent of the patients stated that the quality of central vision increased and that color vision, contrast sensitivity, and distortion improved. We did not encounter any serious adverse events related to the application of subliminal micropulse yellow laser. The subliminal micropulse yellow laser seems to be a therapeutic, effective, and safe option for the treatment of non-inflammatory and resistant cystoid macular edema secondary to retinitis pigmentosa patients.
ClinicalTrials.gov
ID: NCT04234438, January 17, 2020.</abstract><cop>London</cop><pub>Springer London</pub><pmid>32363437</pmid><doi>10.1007/s10103-020-03031-0</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4146-8083</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0268-8921 |
| ispartof | Lasers in medical science, 2021-03, Vol.36 (2), p.317-323 |
| issn | 0268-8921 1435-604X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2398162636 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Acuity Adolescent Adult Adverse events Aged Color sensitivity Color vision Dentistry Edema Eye (anatomy) Female Humans Inflammation Laser applications Laser Therapy Lasers Macular Edema - etiology Macular Edema - physiopathology Macular Edema - surgery Male Medicine Medicine & Public Health Middle Aged Optical Devices Optics Original Article Patients Photonics Prospective Studies Quantum Optics Retinitis Retinitis pigmentosa Retinitis Pigmentosa - complications Statistical analysis Thickness Visual Acuity Young Adult |
| title | Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A14%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20cystoid%20macular%20edema%20secondary%20to%20retinitis%20pigmentosa%20via%20subliminal%20micropulse%20yellow%20laser&rft.jtitle=Lasers%20in%20medical%20science&rft.au=Arslan,%20Umut&rft.date=2021-03-01&rft.volume=36&rft.issue=2&rft.spage=317&rft.epage=323&rft.pages=317-323&rft.issn=0268-8921&rft.eissn=1435-604X&rft_id=info:doi/10.1007/s10103-020-03031-0&rft_dat=%3Cproquest_cross%3E2489035728%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489035728&rft_id=info:pmid/32363437&rfr_iscdi=true |